XML 60 R50.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCKHOLDERS’ EQUITY - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Sep. 30, 2024
Number of Shares      
Outstanding at beginning of period (in shares) 461,710    
Granted (in shares) 0 0  
Exercised (in shares) (66,200)    
Canceled (in shares) 0    
Outstanding at end of period (in shares) 395,510   461,710
Weighted-Average Exercise Price      
Outstanding at beginning of period (in dollars per share) $ 8.00    
Granted (in dollars per share) 0    
Exercised (in dollars per share) 2.68    
Canceled (in dollars per share) 0    
Outstanding at end of period (in dollars per share) $ 8.89   $ 8.00
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Vested and Expected to Vest (in shares) 395,510    
Exercisable (in shares) 395,510    
Vested and Expected to Vest, Weighted-Average Exercise Price (in dollars per share) $ 8.89    
Exercisable, Weighted-Average Exercise Price (in dollars per share) $ 8.89    
Outstanding, Weighted-Average Remaining Contractual Terms (in Years) 2 years 10 months 24 days   2 years 8 months 12 days
Vested and Expected to Vest, Weighted-Average Remaining Contractual Term (in Years) 2 years 10 months 24 days    
Exercisable, Weighted-Average Remaining Contractual Term (in Years) 2 years 10 months 24 days    
Outstanding, Aggregate Intrinsic Value $ 886   $ 1,183
Exercised, Aggregate Intrinsic Value 410    
Vested and Expected to Vest, Aggregate Intrinsic Value 886    
Exercisable, Aggregate Intrinsic Value $ 886